Incidence of giant cell arteritis in western Norway 1972- 2012: a retrospective cohort study. Arthritis Res Ther. 2017;19:278. doi: 673. Salvarani C, Macchioni PL, Tartoni PL, Rossi F, Baricchi R, Castri C, Chiaravalloti F, Portioli I. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol. 1987;5:205 215. 674. Samson M, Jacquin A, Audia S, Daubail B, Devilliers H, Petrella T, Martin L, Durier J, Besancenot JF, Lorcerie B, et al. Stroke associated with giant CLINICAL STATEMENTS AND GUIDELINES Kleindorfer cell arteritis: a population-based study. J Neurol Neurosurg Psychiatry. 675. Chevalet P, Barrier JH, Pottier P, Magadur-Joly G, Pottier MA, Hamidou M, Planchon B, El Kouri D, Connan L, Dupond JL, et al. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year fol- lowup study of 164 patients. J Rheumatol. 2000;27:1484 1491. 676. Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G. The fast- track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology (Oxford). 677. Gonz lez-Gay MA, Blanco R, Rodr guez-Valverde V, Mart nez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 1998;41:1497 1504. doi: 678. Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ. Treatment of giant cell arteri- tis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 679. Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Pe a-Sagredo JL, Martin J, Gonzalez-Gay MA. 